TEC logo

Tecnovatica S.A. Stock Price

WSE:TEC Community·zł3.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

TEC Share Price Performance

zł0.32
-0.09 (-22.93%)
zł0.32
-0.09 (-22.93%)
Price zł0.32

TEC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Proven track record with adequate balance sheet.

3 Risks
1 Reward

Tecnovatica S.A. Key Details

zł52.6k

Revenue

zł0

Cost of Revenue

zł52.6k

Gross Profit

-zł17.2k

Other Expenses

zł69.8k

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
0.0065
100.00%
132.60%
26.5%
View Full Analysis

About TEC

Founded
2010
Employees
n/a
CEO
Michal Marczuk
WebsiteView website
www.tecnovatica.pl

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in January 2026. Tecnovatica S.A. was incorporated in 2010 and is headquartered in Warsaw, Poland.

Recent TEC News & Updates

Recent updates

No updates